Shell Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53K | Sell |
1,453
-694
| -32% | -$25.3K | ﹤0.01% | 1136 |
|
|
2025
Q1 | $78K | Sell |
2,147
-93
| -4% | -$3.38K | ﹤0.01% | 1063 |
|
|
2024
Q4 | $94K | Sell |
2,240
-15
| -0.7% | -$629 | ﹤0.01% | 1058 |
|
|
2024
Q3 | $125K | Buy |
+2,255
| New | +$125K | 0.01% | 994 |
|
|
2024
Q1 | $98K | Sell |
2,386
-247
| -9% | -$10.1K | ﹤0.01% | 1030 |
|
|
2023
Q4 | $126K | Sell |
2,633
-792
| -23% | -$37.9K | 0.01% | 1003 |
|
|
2023
Q3 | $122K | Sell |
3,425
-54
| -2% | -$1.92K | 0.01% | 1039 |
|
|
2023
Q2 | $160K | Sell |
3,479
-20
| -0.6% | -$920 | 0.01% | 992 |
|
|
2023
Q1 | $140K | Sell |
3,499
-12
| -0.3% | -$480 | 0.01% | 1030 |
|
|
2022
Q4 | $163K | Sell |
3,511
-713
| -17% | -$33.1K | 0.01% | 1024 |
|
|
2022
Q3 | $175K | Sell |
4,224
-1,105
| -21% | -$45.8K | 0.01% | 1056 |
|
|
2022
Q2 | $318K | Buy |
5,329
+8
| +0.2% | +$477 | 0.01% | 949 |
|
|
2022
Q1 | $386K | Sell |
5,321
-787
| -13% | -$57.1K | 0.01% | 936 |
|
|
2021
Q4 | $514K | Buy |
6,108
+21
| +0.3% | +$1.77K | 0.01% | 888 |
|
|
2021
Q3 | $549K | Sell |
6,087
-260
| -4% | -$23.5K | 0.01% | 823 |
|
|
2021
Q2 | $605K | Buy |
6,347
+340
| +6% | +$32.4K | 0.01% | 827 |
|
|
2021
Q1 | $684K | Buy |
6,007
+1,840
| +44% | +$210K | 0.01% | 712 |
|
|
2020
Q4 | $577K | Sell |
4,167
-681
| -14% | -$94.3K | 0.01% | 732 |
|
|
2020
Q3 | $398K | Hold |
4,848
| – | – | 0.01% | 779 |
|
|
2020
Q2 | $379K | Sell |
4,848
-82
| -2% | -$6.41K | 0.01% | 788 |
|
|
2020
Q1 | $219K | Sell |
4,930
-75
| -1% | -$3.33K | 0.01% | 982 |
|
|
2019
Q4 | $214K | Sell |
5,005
-135
| -3% | -$5.77K | ﹤0.01% | 1124 |
|
|
2019
Q3 | $220K | Sell |
5,140
-44
| -0.8% | -$1.88K | 0.01% | 1111 |
|
|
2019
Q2 | $329K | Sell |
5,184
-117
| -2% | -$7.43K | 0.01% | 1046 |
|
|
2019
Q1 | $368K | Hold |
5,301
| – | – | 0.01% | 1012 |
|
|
2018
Q4 | $230K | Sell |
5,301
-400
| -7% | -$17.4K | 0.01% | 1022 |
|
|
2018
Q3 | $435K | Buy |
+5,701
| New | +$435K | 0.01% | 997 |
|